UB Paderborn / Katalog / Suche / in CDI

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 5.040

Sortiert nach

Once‐weekly parathyroid hormone combined with ongoing long‐term alendronate treatment promotes osteoporotic fracture healing in ovariectomized rats

Journal of orthopaedic research, 2021-10, Vol.39 (10), p.2103-2115

2021

Volltextzugriff (PDF)

Evaluating two nanocarrier systems for the transdermal delivery of sodium alendronate

International journal of pharmaceutics, 2020-05, Vol.582, p.119312, Article 119312

2020

Volltextzugriff (PDF)

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

The New England journal of medicine, 2017-10, Vol.377 (15), p.1417-1427

2017

Volltextzugriff (PDF)

Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma

ACS applied materials & interfaces, 2019-02, Vol.11 (7), p.7357-7368

2019

Volltextzugriff (PDF)

Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

Journal of bone and mineral research, 2010-01, Vol.25 (1), p.72-81

2010

Volltextzugriff (PDF)

Administration of teriparatide for four years cyclically compared to two years daily in treatment Naïve and alendronate treated women

Bone (New York, N.Y.), 2019-03, Vol.120, p.246-253

2019

Volltextzugriff (PDF)

Targeting therapeutics to bone by conjugation with bisphosphonates

Current opinion in pharmacology, 2018-06, Vol.40, p.87-94

2018

Volltextzugriff (PDF)

Bone-targeted delivery of nanodiamond-based drug carriers conjugated with alendronate for potential osteoporosis treatment

Journal of controlled release, 2016-06, Vol.232, p.152-160

2016

Volltextzugriff (PDF)

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

Osteoporosis international, 2012-01, Vol.23 (1), p.317-326

2012

Volltextzugriff (PDF)

Poly(ethylene glycol)–paclitaxel–alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases

Biomaterials, 2013-05, Vol.34 (15), p.3795-3806

2013

Volltextzugriff (PDF)

Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors

International journal of biological macromolecules, 2020-12, Vol.164, p.2583-2597

2020

Volltextzugriff (PDF)

Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate

Journal of bone and mineral research, 2010-08, Vol.25 (8), p.1886-1894

2010

Volltextzugriff (PDF)

Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer

Journal of controlled release, 2017-10, Vol.264, p.76-88

2017

Volltextzugriff (PDF)

Polycaprolactone-Coated 3D Printed Tricalcium Phosphate Scaffolds for Bone Tissue Engineering: In Vitro Alendronate Release Behavior and Local Delivery Effect on In Vivo Osteogenesis

ACS applied materials & interfaces, 2014-07, Vol.6 (13), p.9955-9965

2014

Volltextzugriff (PDF)

Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system

European journal of pharmaceutical sciences, 2012-08, Vol.46 (5), p.500-507

2012

Volltextzugriff (PDF)

Multivariate Modulation of the Zr MOF UiO‐66 for Defect‐Controlled Combination Anticancer Drug Delivery

Angewandte Chemie (International ed.), 2020-03, Vol.59 (13), p.5211-5217

International ed. in English, 2020

Volltextzugriff (PDF)

A longitudinal HR‐pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover

Journal of bone and mineral research, 2010-12, Vol.25 (12), p.2558-2571

2010

Volltextzugriff (PDF)

Enhanced oral delivery of alendronate by sucrose fatty acids esters in rats and their absorption-enhancing mechanisms

International journal of pharmaceutics, 2016-12, Vol.515 (1-2), p.476-489

2016

Volltextzugriff (PDF)

Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy

Journal of bone and mineral research, 2024-05, Vol.39 (4), p.417-424

2024

Volltextzugriff (PDF)

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density

Osteoporosis international, 2018-06, Vol.29 (6), p.1407-1417

2018

Volltextzugriff (PDF)

Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass

Nature medicine, 2012-03, Vol.18 (3), p.456-462

2012

Volltextzugriff (PDF)

Quercetin suppresses ovariectomy-induced osteoporosis in rat mandibles by regulating autophagy and the NLRP3 pathway

Experimental biology and medicine (Maywood, N.J.), 2023-12, Vol.248 (23), p.2363-2380

2023

Volltextzugriff (PDF)

Axial Compressive Loading Attenuates Early Osteoarthritis by Reducing Subchondral Bone Remodeling

The American journal of sports medicine, 2023-06, Vol.51 (7), p.1752-1764

2023

Volltextzugriff (PDF)

Efficacy and safety of a once‐yearly i.v. Infusion of zoledronic acid 5 mg versus a once‐weekly 70‐mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double‐blind, active‐controlled study

Journal of bone and mineral research, 2010-10, Vol.25 (10), p.2239-2250

2010

Volltextzugriff (PDF)

Dendritic Poly(ethylene glycol) Bearing Paclitaxel and Alendronate for Targeting Bone Neoplasms

Molecular pharmaceutics, 2011-08, Vol.8 (4), p.1063-1072

2011

Volltextzugriff (PDF)

1 – 25 von 5.040

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.358)
Mit Volltextzugriff
(4.070)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

n.n

Thema

Science & Technology
(3.739)
Life Sciences & Biomedicine
(3.429)
Humans
(3.119)
Female
(2.605)
Alendronate
(2.383)
Alendronate - Therapeutic Use
(1.886)
Osteoporosis
(1.663)
Aged
(1.339)
Middle Aged
(1.330)
Male
(1.248)
Animals
(1.127)
Biological And Medical Sciences
(1.077)
Bisphosphonates
(1.064)
Bone Density Conservation Agents - Therapeutic Use
(1.008)
Medical Sciences
(995)
Alendronate - Administration & Dosage
(940)
Alendronate - Pharmacology
(936)
Endocrinology & Metabolism
(921)
Osteoporosis, Postmenopausal - Drug Therapy
(900)
Bone Density - Drug Effects
(887)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(4.040)
IngentaConnect Journals
(2.453)
Journals@Ovid
(1.980)
EZB Free E-Journals
(1.950)
IngentaConnect Journals
(1.022)
NUS Single-Journal Subscriptions
(1.022)
SpringerLink
(901)
Elsevier ScienceDirect Journals Complete
(890)
Wiley Online Library - AutoHoldings Journals
(703)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(664)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(608)
Wiley Online Library
(560)
Oxford University Press Journals Current
(325)
Taylor & Francis Journals Auto-Holdings Collection
(250)
Taylor & Francis Current Content
(196)
Taylor & Francis Journals Complete
(186)
Oxford Journals 2020 Medicine
(140)
Nexis Uni
(124)
Sage Journals
(77)
Nature Journals
(69)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(14)